1 Min Read
* Sumitomo dainippon pharma says u.s. Unit agrees to buy cynapsus therapeutics for about $624 million Source text for Eikon: Further company coverage: [ ]
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.